← Open Payments lookup

NALINI AGARWAL: Open Payments

NPI 1073603213 · SOUTHGATE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$403 in 14 payments from 11 companies in 2025. Trend: 2023 $17 · 2024 $346 · 2025 $403

Food & beverage: $403
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$120
Janssen Pharmaceuticals, Inc2$51
Teva Pharmaceuticals USA, Inc.2$45
Otsuka America Pharmaceutical, Inc.2$33
ABBVIE INC.1$28
Sage Therapeutics, LLC1$27
Supernus Pharmaceuticals, Inc.1$23
Neurocrine BioSciences, Inc.1$22
Axsome Therapeutics, Inc.1$21
Noven Therapeutics, LLC1$17

Products named: CAPLYTA, INVEGA SUSTENNA, UZEDY, VRAYLAR, ZURZUVAE, Qelbree, INGREZZA, Auvelity.

Industry payments across MI — which companies pay providers there.